HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Florence Wong Selected Research

Hepatorenal Syndrome

1/2022Management of hepatorenal syndrome in liver cirrhosis: a recent update.
1/2021Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
1/2017Terlipressin Improves Renal Function and Reverses Hepatorenal Syndrome in Patients With Systemic Inflammatory Response Syndrome.
9/2016Diagnosing and treating renal disease in cirrhotic patients.
6/2016Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.
12/2015The evolving concept of acute kidney injury in patients with cirrhosis.
7/2015Pretransplant Type 2 Hepatorenal Syndrome Is Associated With Persistently Impaired Renal Function After Liver Transplantation.
6/2015Treatment to improve acute kidney injury in cirrhosis.
3/2015Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation.
9/2011Hepatorenal syndrome: do the vasoconstrictors work?
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Florence Wong Research Topics

Disease

51Fibrosis (Cirrhosis)
06/2022 - 06/2002
34Ascites
06/2022 - 01/2003
18Hepatorenal Syndrome
01/2022 - 03/2003
15Infections
01/2021 - 12/2012
15End Stage Liver Disease
11/2020 - 12/2008
11Hepatic Encephalopathy
04/2022 - 09/2005
10Liver Diseases (Liver Disease)
11/2020 - 11/2002
10Acute Kidney Injury (Acute Renal Failure)
03/2020 - 05/2011
6Peritonitis
01/2021 - 12/2006
5Portal Hypertension
06/2022 - 01/2006
5Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 08/2010
5Acute-On-Chronic Liver Failure
01/2021 - 01/2007
4Bacterial Infections (Bacterial Infection)
01/2020 - 06/2015
4Shock
01/2018 - 01/2012
3Chronic Renal Insufficiency
01/2022 - 07/2015
3Respiratory Insufficiency (Respiratory Failure)
01/2022 - 04/2017
3Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
01/2021 - 01/2019
3Neoplasms (Cancer)
01/2020 - 12/2002
3Hemorrhage
01/2019 - 01/2006
3Chronic Hepatitis C
01/2019 - 12/2016
3Hyponatremia
01/2018 - 01/2003
2Abdominal Pain (Pain, Abdominal)
01/2021 - 09/2005
2Inflammation (Inflammations)
03/2020 - 10/2019
2Non-alcoholic Fatty Liver Disease
01/2019 - 11/2003
2Varicose Veins (Varicose Vein)
01/2019 - 01/2006
2Cardiac Sudden Death (Sudden Cardiac Arrest)
03/2017 - 01/2012
2Body Weight (Weight, Body)
06/2015 - 07/2008
2Hypotension (Low Blood Pressure)
08/2010 - 01/2008
2Heart Failure
03/2009 - 01/2003
2Hydrothorax
11/2006 - 01/2006
1Kidney Diseases (Kidney Disease)
01/2022
1COVID-19
01/2021
1Pneumonia (Pneumonitis)
01/2021
1Diarrhea
01/2021
1Nausea
01/2021
1Cellulitis
08/2020
1Alcoholic Hepatitis
01/2020
1HIV Infections (HIV Infection)
01/2020
1Chronic Disease (Chronic Diseases)
10/2019
1Sarcopenia
04/2019
1Dysbiosis
01/2019

Drug/Important Bio-Agent (IBA)

20SodiumIBA
06/2022 - 06/2002
17CreatinineIBA
01/2022 - 01/2008
17AlbuminsIBA
01/2021 - 07/2004
16DiureticsIBA
11/2019 - 03/2003
10Vasoconstrictor AgentsIBA
01/2021 - 03/2003
6Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 04/2015
5Rifaximin (L 105)FDA Link
01/2021 - 04/2015
5ReninIBA
01/2020 - 07/2004
5satavaptanIBA
10/2018 - 07/2008
5Vasopressins (Vasopressin)IBA
06/2013 - 01/2003
4TerlipressinIBA
01/2022 - 06/2016
4Antiviral Agents (Antivirals)IBA
01/2019 - 08/2005
3AngiotensinsIBA
01/2020 - 08/2010
3Serum AlbuminIBA
01/2019 - 12/2012
3Proton Pump InhibitorsIBA
01/2019 - 04/2015
3AldosteroneIBA
10/2016 - 07/2004
3Antidiuretic Hormone Receptor AntagonistsIBA
08/2010 - 01/2003
3Spironolactone (Aldactone)FDA LinkGeneric
08/2010 - 07/2003
2Pharmaceutical PreparationsIBA
01/2021 - 01/2007
2glecaprevir and pibrentasvirIBA
10/2020 - 01/2019
2Natriuretic AgentsIBA
01/2020 - 06/2002
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020 - 01/2019
2Neurotransmitter Agents (Neurotransmitter)IBA
10/2016 - 03/2010
2Angiotensin IIIBA
10/2016 - 03/2003
2Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
01/2012 - 08/2010
2Losartan (Cozaar)FDA LinkGeneric
09/2006 - 06/2002
1Thyroxine (Levothyroxine)FDA LinkGeneric
04/2022
1LipidsIBA
11/2020
1Lactic Acid (Lactate)FDA LinkGeneric
11/2020
1P-300IBA
10/2020
1renalaseIBA
01/2020
1ElectrolytesIBA
01/2020
1Chymases (Chymase)IBA
01/2020
1Cytidine Triphosphate (CTP)IBA
01/2020
1Calcimimetic AgentsIBA
01/2020
1CatecholaminesIBA
01/2020
1CalciumIBA
01/2020
1Prealbumin (Transthyretin)IBA
01/2020
1Calcium-Sensing ReceptorsIBA
01/2020
1Bacterial DNAIBA
10/2019
1glecaprevirIBA
01/2019
1pibrentasvirIBA
01/2019

Therapy/Procedure

20Liver Transplantation
06/2022 - 11/2002
18Therapeutics
01/2021 - 03/2003
17Transjugular Intrahepatic Portasystemic Shunt
06/2022 - 03/2003
11Surgical Portasystemic Shunt (Portosystemic Shunt)
01/2020 - 03/2003
8Stents
06/2022 - 03/2003
4Transplantation
01/2020 - 11/2002
3Length of Stay
01/2021 - 01/2016
2Palliative Care (Palliative Therapy)
06/2022 - 10/2018
2Kidney Transplantation
01/2022 - 02/2011
2Renal Replacement Therapy (Therapies, Renal Replacement)
01/2021 - 03/2020
2Catheters
08/2020 - 12/2012
2Artificial Respiration (Mechanical Ventilation)
01/2018 - 01/2014
2Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
03/2017 - 01/2012
2Radiofrequency Ablation
04/2005 - 12/2002
1Terminal Care (Care, Terminal)
10/2019
1Ligation
01/2019
1Contraindications
01/2019